Table 1.
Substrate | Reduced β-Cys93 | met-Hb (%) | mol met-Hb formed per mol of HONH-Substrate or H2Oa |
---|---|---|---|
Hb + H2O | 2.00 ± 0.10 | 2.5 ± 0.14 | 0.03 |
Hb +HONH-MeIQx | 1.96 ± 0.10 | 3.7 ± 0.18 | 0.05 |
Hb +HONH-PhIP | 1.81 ± 0.10 | 4.7 ± 0.20 | 0.06 |
Hb +HONH-ABP | <0.10 ± 0.01 | 41.4 ± 0.33 | 0.55 |
Hb+HONH-AαC | <0.10 ± 0.02 | 48.8 ± 0.31 | 0.64 |
HbO2 (tetramer) content of RBC was adjusted to 2 nmol and RBC were incubated with 6 nmol of HONH-AA or HONH-HAA for 30 min, followed by titration with PMB.
met-Hb formation in the presence or absence of HONH-AA or HONH-HAA (mol/mol); mol of met-Hb formation in the H2O control was normalized to the ratio of the HONH-substrate treated cells by dividing amount of met-Hb formed by 6. Each value represents the mean and standard deviation of three experiments.